The aim of this paper is to investigate interprofessional collaboration between general practitioners (GPs) and pharmacists involved in the delivery of enhanced pharmacy services under the local pharmaceutical services (LPS) contract in England. Previous research suggests that a number of interprofessional barriers exist between community pharmacists and GPs which hinders the integration of community pharmacists into the primary health care team (PHCT). One of the aims of the LPS contract, introduced in England in 2002 as an alternative to national contractual arrangements, was to enable pharmacists to work more closely with other health care professionals. A two-stage survey was distributed to all pharmacists involved in the first wave of ...
Abstract Background Increased patient demand for healthcare services coupled with a shortage of gene...
This is a short case study how community pharmacy and pharmacists part of the NHS England GP Practic...
Despite having been described by the then (2003) Chief Pharmaceutical Officer for England as ·probab...
Interprofessional collaboration between community pharmacists and general practitioners is essential...
To improve the outcomes of drug therapy, there is increasing interest in the community pharmacist pr...
Background: The NHS in the UK supports pharmacists’ deployment into general practices. This article ...
Effective interprofessional collaboration is critical for sustaining high quality care in the contex...
Community pharmacies and pharmacists predominantly operate in a retail environment independently of ...
Background: Healthcare authorities worldwide search for ways to develop integrated care and interpro...
AbstractPharmaceutical care (PC) involves the active participation of the pharmacist in the improvem...
The Community Pharmacy Medicines Management Project (CPMMP) was a multi-centre randomised, controlle...
Background: A number of key publications in recent years have advocated a more integrated vision of ...
The Community Pharmacy Medicines Management Project (CPMMP) was a multi-centre randomised, controlle...
yesBackground: The NHS in the UK supports pharmacists’ deployment into general practices. This arti...
Magister Pharmaceuticae - MPharmThe global movement towards enhancing inter-professional collaborati...
Abstract Background Increased patient demand for healthcare services coupled with a shortage of gene...
This is a short case study how community pharmacy and pharmacists part of the NHS England GP Practic...
Despite having been described by the then (2003) Chief Pharmaceutical Officer for England as ·probab...
Interprofessional collaboration between community pharmacists and general practitioners is essential...
To improve the outcomes of drug therapy, there is increasing interest in the community pharmacist pr...
Background: The NHS in the UK supports pharmacists’ deployment into general practices. This article ...
Effective interprofessional collaboration is critical for sustaining high quality care in the contex...
Community pharmacies and pharmacists predominantly operate in a retail environment independently of ...
Background: Healthcare authorities worldwide search for ways to develop integrated care and interpro...
AbstractPharmaceutical care (PC) involves the active participation of the pharmacist in the improvem...
The Community Pharmacy Medicines Management Project (CPMMP) was a multi-centre randomised, controlle...
Background: A number of key publications in recent years have advocated a more integrated vision of ...
The Community Pharmacy Medicines Management Project (CPMMP) was a multi-centre randomised, controlle...
yesBackground: The NHS in the UK supports pharmacists’ deployment into general practices. This arti...
Magister Pharmaceuticae - MPharmThe global movement towards enhancing inter-professional collaborati...
Abstract Background Increased patient demand for healthcare services coupled with a shortage of gene...
This is a short case study how community pharmacy and pharmacists part of the NHS England GP Practic...
Despite having been described by the then (2003) Chief Pharmaceutical Officer for England as ·probab...